LEADER 01606nam  2200397Ia 450 
001 9910698838503321
005 20090521122751.0
035   $a(CKB)5470000002397482
035   $a(OCoLC)334847937
035   $a(EXLCZ)995470000002397482
100   $a20090521d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $euse of nucleic acid tests on pooled and individual samples from donors of whole blood and plasma components (including source plasma and source leukocytes) to adequately and appropriately reduce the risk of transmission of HIV-1 and HCV
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2004]
215   $ai, 11 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 21, 2009).
300   $a"October 2004".
320   $aIncludes bibliographic references (page 11).
517   $aGuidance for industry 
606   $aNucleic acids$zUnited States$xTesting
606   $aBlood$xExamination$zUnited States
606   $aHIV (Viruses)$zUnited States$xPrevention
615  0$aNucleic acids$xTesting.
615  0$aBlood$xExamination
615  0$aHIV (Viruses)$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698838503321
996   $aGuidance for industry$93434577
997   $aUNINA